Applied VR

🔍 NEW PUBLICATION ALERT 🔬

The FDA-authorized RelieVRx program delivers a breakthrough research for treating patients with high-impact chronic pain.

In a large randomized controlled trial (n=1000+):
➡️ 70% of high-impact chronic pain patients converted to low-impact status after completing the RelieVRx program.
➡️ 67% maintained that status at 12 months after therapy

The study appears in Scientific Reports as part of the special collection: "Risk Factors of Chronic Pain and Approaches to Pain Management."

This marks a major shift in immersive therapeutics:
AppliedVR’s home-based VR-therapy works, and it works best for the people who need it most.

The implications are massive, for patients, providers and healthcare systems. As healthcare systems seek innovative strategies to manage chronic lower back pain, the evidence for RelieVRx, a home-based VR therapy, offers a critical new option.

We’ll break down what this means for healthcare costs, patient care models, and the future of pain management strategies this week. Stay tuned or click the link to learn more!

https://www.relievrx.com/news-and-media